全文获取类型
收费全文 | 4569篇 |
免费 | 398篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 145篇 |
妇产科学 | 84篇 |
基础医学 | 575篇 |
口腔科学 | 75篇 |
临床医学 | 606篇 |
内科学 | 858篇 |
皮肤病学 | 158篇 |
神经病学 | 355篇 |
特种医学 | 359篇 |
外科学 | 557篇 |
综合类 | 83篇 |
一般理论 | 4篇 |
预防医学 | 430篇 |
眼科学 | 59篇 |
药学 | 290篇 |
中国医学 | 16篇 |
肿瘤学 | 248篇 |
出版年
2023年 | 25篇 |
2021年 | 66篇 |
2020年 | 35篇 |
2019年 | 55篇 |
2018年 | 86篇 |
2017年 | 63篇 |
2016年 | 65篇 |
2015年 | 81篇 |
2014年 | 103篇 |
2013年 | 158篇 |
2012年 | 203篇 |
2011年 | 206篇 |
2010年 | 154篇 |
2009年 | 167篇 |
2008年 | 181篇 |
2007年 | 164篇 |
2006年 | 175篇 |
2005年 | 165篇 |
2004年 | 159篇 |
2003年 | 136篇 |
2002年 | 140篇 |
2001年 | 121篇 |
2000年 | 107篇 |
1999年 | 110篇 |
1998年 | 89篇 |
1997年 | 90篇 |
1996年 | 99篇 |
1995年 | 75篇 |
1994年 | 68篇 |
1993年 | 78篇 |
1992年 | 100篇 |
1991年 | 73篇 |
1990年 | 117篇 |
1989年 | 123篇 |
1988年 | 111篇 |
1987年 | 104篇 |
1986年 | 108篇 |
1985年 | 96篇 |
1984年 | 77篇 |
1983年 | 47篇 |
1982年 | 51篇 |
1981年 | 40篇 |
1979年 | 41篇 |
1978年 | 29篇 |
1977年 | 41篇 |
1976年 | 41篇 |
1975年 | 38篇 |
1973年 | 32篇 |
1971年 | 28篇 |
1970年 | 29篇 |
排序方式: 共有4984条查询结果,搜索用时 0 毫秒
81.
82.
Heart block in posterior and anterior myocardial infarction 总被引:10,自引:0,他引:10
R M Norris 《British heart journal》1969,31(3):352-356
83.
84.
G B Mancini R A Slutsky S L Norris V Bhargava W L Ashburn C B Higgins 《The American journal of cardiology》1983,51(1):43-51
Using gated equilibrium radionuclide angiography, variables of diastolic filling were analyzed at rest and during supine bicycle exercise in normal subjects (Group 1, n = 18), coronary patients with normal resting ejection fractions (Group 2, n = 26), and coronary patients with reduced resting ejection fractions (Group 3, n = 8). Indexes analyzed were peak filling rate and filling fraction during the first third of diastole. At rest, the peak filling rate was significantly lower in coronary patients than in normal subjects (3.18 +/- 0.82 end-diastolic volume [EDV]/s in Group 1 versus 2.41 +/- 0.66 EDV/s in Group 2, p less than 0.005; and 1.34 +/- 0.26 EDV/s in Group 3, p less than 0.001 versus Group 1). These differences persisted at peak exercise. Coronary patients also had significantly lower filling fractions at rest and during exercise than did normal control subjects. The time from end-systole to peak filling rate was longer at rest in patients in Group 2 (203 +/- 52 ms) than in subjects in Group 1 (172 +/- 50 ms, p less than 0.025). This remained true when the time to peak filling was normalized by the R-R interval. Although the exercise time to peak filling was longer in coronary patients in both Groups 2 and 3 than in Group 1, these differences were not apparent when the interval was normalized by the R-R interval. Thus, abnormalities in peak filling rate and filling fraction exist in patients with coronary disease both at rest and during exercise, but large overlaps exist between normal and coronary patients. Caution is advised in comparing the timing of events during diastole because apparent group differences may be related in part to rest or exercise heart rate. 相似文献
85.
86.
Narayan KM Benjamin E Gregg EW Norris SL Engelgau MM 《Annals of internal medicine》2004,140(11):958-963
Translation research transforms currently available knowledge into useful measures for everyday clinical and public health practice. We review the progress in diabetes translation research and identify future challenges and opportunities in this field. Several promising interventions to optimize implementation of efficacious diabetes treatments are available. Many of these interventions, singly or in combination, need to be more formally tested in larger randomized or quasi-experimental practical trials using outcomes of special interest to patients (for example, patient satisfaction and quality of life) and policymakers (for example, cost and cost-effectiveness). The long-term outcomes (such as morbidity, mortality, quality of life, and costs) of strategies aimed at improving diabetes care must be assessed. Translation research also needs to incorporate ways of studying complex systems of care. The challenges and opportunities offered by translation research are tremendous. 相似文献
87.
Foy CG Hsu FC Haffner SM Norris JM Rotter JI Henkin LF Bryer-Ash M Chen YD Wagenknecht LE 《American journal of hypertension》2008,21(8):910-916
BackgroundWe examined the relationship between visceral adipose tissue (VAT), independent of overall adiposity, and prevalent hypertension among adults enrolled in the Insulin Resistance Atherosclerosis (IRAS) Family Study. We also examined the role of insulin sensitivity (S(I)) upon hypertension. This was a cross-sectional epidemiological study in which African-American and Hispanic-American families were recruited from three clinical sites. The main outcome measure was prevalent hypertension, as defined by standardized protocol.MethodsThe relationship between VAT and prevalent hypertension was examined in adjusted marginal models among 1,582 participants. All continuous variables were standardized.ResultsA significant VAT by gender interaction prompted separate analyses for VAT according to gender. Further adjustment for S(I) was performed to determine its potential roles in the VAT-hypertension relationship. The mean age (s.d.) of the sample was 41.3 (13.8) years, with a mean body mass index (BMI) (s.d.) of 28.7 (6.0) kg/m(2). Women comprised 58.5% of the sample (N = 925), and Hispanic Americans comprised 69.2% of the sample (N = 1,095). One in five participants (21.2%) had prevalent hypertension. In women, VAT was significantly associated with hypertension, independent of BMI (odds ratio (OR) = 1.49, P = 0.006). African-American women demonstrated increased odds of prevalent hypertension compared to Hispanic-American women (OR = 3.08, P < 0.001). Among men, VAT was not associated with hypertension independent of BMI, and BMI explained a significant amount of the variation in hypertension.ConclusionsA significant relationship may exist between VAT and hypertension among women, but not among men. The relationship between VAT and hypertension in women was not associated with insulin resistance.American Journal of Hypertension (2008). doi:10.1038/ajh.2008.213American Journal of Hypertension (2008); 21, 8, 910-916. doi:10.1038/ajh.2008.213. 相似文献
88.
Widayanti Anna Wahyuni Norris Pauline Heydon Susan Green James A. 《International journal of clinical pharmacy》2020,42(1):31-39
International Journal of Clinical Pharmacy - Background Medicine-taking behaviour of people in Indonesia is particularly complex because of Indonesia’s pluralistic health system, in which... 相似文献
89.
Satyan S. Kalkunte Stefan Neubeck Wendy E. Norris Shi-Bin Cheng Stefan Kostadinov Dang Vu Hoang Aftab Ahmed Ferdinand von Eggeling Zahir Shaikh James Padbury Goran Berg Anders Olofsson Udo R. Markert Surendra Sharma 《The American journal of pathology》2013,183(5):1425-1436
Preeclampsia is a major pregnancy complication with potential short- and long-term consequences for both mother and fetus. Understanding its pathogenesis and causative biomarkers is likely to yield insights for prediction and treatment. Herein, we provide evidence that transthyretin, a transporter of thyroxine and retinol, is aggregated in preeclampsia and is present at reduced levels in sera of preeclamptic women, as detected by proteomic screen. We demonstrate that transthyretin aggregates form deposits in preeclampsia placental tissue and cause apoptosis. By using in vitro approaches and a humanized mouse model, we provide evidence for a causal link between dysregulated transthyretin and preeclampsia. Native transthyretin inhibits all preeclampsia-like features in the humanized mouse model, including new-onset proteinuria, increased blood pressure, glomerular endotheliosis, and production of anti-angiogenic factors. Our findings suggest that a focus on transthyretin structure and function is a novel strategy to understand and combat preeclampsia.Preeclampsia occurs in 5% to 8% of pregnancies worldwide and is a major cause of fetal and maternal morbidity and mortality.1–3 It is a heterogeneous disease with varied presentations from mild self-limited hypertension and proteinuria to severe forms with significant end-organ dysfunction and HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets).3 Although the cause of preeclampsia and its appropriate treatment remain elusive, this syndrome has been proposed to reflect at least two stages of complications during pregnancy. These begin with preclinical manifestations at the maternal-fetal interface, followed by systemic clinical symptoms.1,2 Hypertension, proteinuria, and edema, with a variable degree of fetal growth restriction, are the cardinal features of preeclampsia.3 Because the placenta is the nutritional and immunological gateway to normal fetal development and pregnancy outcome, placenta-related events are believed to be central to the pathogenesis of this disease. Evidence exists for the release of disease-initiating molecules into maternal circulation that triggers the clinical symptoms.1,4 Placental and systemic anomalies reflected by circulating placental debris, inflammation, impaired remodeling of spiral arteries, placental hypoxia/ischemia, excess production of anti-angiogenic factors [soluble fms-like tyrosine kinase-1 (sFlt-1)], and soluble endoglin (sEng), and angiotensin receptor autoantibodies have all emerged as contributors to the pathophysiological characteristics of preeclampsia.2,4–14Preeclampsia has remained enigmatic because of lack of well-defined etiology and animal models. Although normal mice do not develop preeclampsia spontaneously, mouse models have been judged to be particularly useful to uterine diseases and pregnancy complications because many similarities in female reproduction and placentation have been identified between the two species.15 Moreover, their tractable genetics provide an effective way to probe mechanisms more deeply than many other species.15–17 We recently showed that sera from preeclamptic women could function as a source of novel causative factors that induced hypertension, proteinuria, and kidney pathological characteristics, as well as intrauterine growth restriction (IUGR), in IL-10−/− mice in a pregnancy-specific manner.18 IL-10 functions as a potent vascular and anti-inflammatory cytokine and has been shown to be present at significantly reduced levels in preeclampsia placental tissue.19,20 Preeclampsia serum (PES) was found to disrupt endovascular cross talk between trophoblasts and endothelial cells and to induce placental hypoxia and excess production of sFlt-1 and sEng,18 soluble factors known to precipitate maternal symptoms.21,22 These results from our serum-based humanized mouse model suggest that the pathophysiological characteristics of preeclampsia are more complex than previously thought and are likely to involve interactions and dysregulation of multiple factors. By using serum proteomic screening by surface-enhanced laser-desorption ionization-time-of-flight (SELDI-TOF), our results suggest that PES contains a reduced abundance of transthyretin, a plasma transport protein for the thyroid hormone, thyroxine, and retinol-binding protein.23 More important, transthyretin has been widely studied for its role in amyloid diseases associated with protein misfolding and aggregation, resulting in deposits of toxic, fibrillar aggregates in specific organs.24–26 Dysregulated or reduced transthyretin has also been implicated in Alzheimer disease, and overexpression of a wild-type human transthyretin transgene has been shown to ameliorate the disease in the transgenic murine model of human Alzheimer disease.27,28 Transthyretin in its native form assumes a homotetrameric quaternary configuration (approximately 14 kDa per monomer). Post-translational modifications of the monomer result in detection of several isoforms.29 Circulating transthyretin is also a validated marker of malnutrition and has a putative role in oocyte maturation and inflammation.30–32 Although the presence of transthyretin during implantation in mice and in the placenta and trophoblasts in humans has been reported,33,34 its functional role in normal pregnancy or adverse pregnancy outcomes has not been recognized. We hypothesize that transthyretin in preeclampsia is structurally and functionally dysregulated and contributes to the onset of this serious pregnancy complication. Herein, we present complementary in vitro and in vivo approaches, which show that endogenously altered transthyretin is a preeclampsia-causing agent and that native transthyretin has the ability to block the onset of preeclampsia-like features. 相似文献
90.
W.R. Wayne Martin MD Michael Miles MD Qiaonan Zhong MD Johanna Hartlein APRN Brad A. Racette MD Scott A. Norris MD Mwiza Ushe MD Baijayanta Maiti MD PhD Susan Criswell MD Albert A. Davis MD PhD Paul T. Kotzbauer MD PhD Nigel J. Cairns PhD Richard J. Perrin MD PhD Joel S. Perlmutter MD 《Movement disorders》2021,36(4):948-954